Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S7 from Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
  1. Home
  2. Publications
  3. Supplementary Figure S7 from Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Supplementary Figure S7 from Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Authors:
  • Marcelo V. Negrao
    Marcelo V. Negrao
  • Haniel A. Araujo
    Haniel A. Araujo
  • Giuseppe Lamberti
    Giuseppe Lamberti
  • Alissa J. Cooper
    Alissa J. Cooper
  • NANeal S. Akhave
    Neal S. Akhave
  • Teng Zhou
    Teng Zhou
  • Lukas Delasos
    Lukas Delasos
  • J. Kevin Hicks
    J. Kevin Hicks
  • Mihaela Aldea
    Mihaela Aldea
  • Gabriele Minuti
    Gabriele Minuti
  • Jacobi Hines
    Jacobi Hines
  • Jacqueline V. Aredo
    Jacqueline V. Aredo

Open Access
Publisher website
Google Scholar
  • 11 December 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2159-8290.30859274
Abstract
Progression-free survival (left) and overall survival (right) according to co-mutation status for (A) CHEK2 and (B) ATRX in the overall mutation-evaluable population.
Keywords
  • LUNG CANCER
  • ONCOGENES & TUMOR SUPPRESSORS
  • KRAS
  • PRECISION MEDICINE
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.